Publications by authors named "L Witkowski"

Purpose: Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is an extremely rare, highly aggressive cancer (mean age of onset, 24 years). Nearly all cases are associated with somatic or germline pathogenic variants (GPVs) in SMARCA4. Early bilateral oophorectomy is recommended for unaffected females with a SMARCA4 GPV.

View Article and Find Full Text PDF
Article Synopsis
  • Li-Fraumeni syndrome (LFS) is linked to harmful mutations in the TP53 gene, leading to an increased risk of developing various cancers, particularly breast cancer.
  • A study reports a family with the TP53 p.R181H variant; while one member was diagnosed with breast cancer at 71, other relatives also had breast cancer after 40, though many did not develop cancer by age 42.
  • Research indicates that the p.R181H variant might have reduced cancer risk and penetrance, especially in younger individuals, consistent with laboratory findings showing it retains some p53 function.
View Article and Find Full Text PDF

A large-scale study was carried out in the Polish goat population in 2014-2021 to determine the herd-level true seroprevalence (HTP) of caseous lymphadenitis (CLA) caused by Corynebacterium pseudotuberculosis (Cp) and paratuberculosis (PTB) caused by Mycobacterium avium ssp. paratuberculosis (Map). Two-stage cluster sampling was applied to herds counting at least 20 adult goats (aged >1 year) and in each herd all males and 10-13 females were tested.

View Article and Find Full Text PDF

Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an autosomal dominant cancer predisposition syndrome characterized by cutaneous leiomyomas, uterine leiomyomas, and aggressive renal cancer. Germline variants in the fumarate hydratase (FH) gene predispose to HLRCC. Identifying germline pathogenic FH variants enables lifetime renal cancer screening and genetic testing for family members.

View Article and Find Full Text PDF

Germline pathogenic variants in predispose individuals to develop a variety of benign and malignant tumors. Accurate variant curation and classification is essential for reliable diagnosis of -related tumor predisposition and identification of individuals who may benefit from surveillance. Since 2015, most labs have followed the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (ACMG/AMP) sequence variant classification guidelines for germline variant curation.

View Article and Find Full Text PDF